Focus. Together. For patients & society
Ipsen (albireopharma.com) earns a Brand Analyzer score of 82 out of 100, placing it in the Strong Brand tier among Healthcare brands. Among 3446 Healthcare brands analyzed, Ipsen ranks in the 86th percentile (category average 72, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 97/100, Digital Presence 88/100, Visual Identity 95/100, Messaging Clarity 95/100, Trust Foundation 89/100, AI Discoverability 75/100, Brand Authority 50/100.
Ipsen is a French global biopharmaceutical company founded in 1929, focused on specialty care and innovation in areas of high unmet medical need, particularly oncology and rare diseases. The company develops and advances a pipeline of medicines aimed at improving patient outcomes for critical and rare conditions. Ipsen serves patients, healthcare providers, and the broader medical and scientific community, positioning itself as an innovation-driven leader in transforming specialty patient care.
| Brand Name | Ipsen |
|---|---|
| Domain | albireopharma.com |
| Industry | Healthcare |
| Founded | 1929 |
| Headquarters | France |
| CEO | David Meek |
| Main Competitors | Sanofi (82/100), Novartis (73/100), Pfizer (89/100), AstraZeneca (82/100), Roche (93/100), Bristol Myers Squibb (84/100), Amgen (82/100) |
Moz Domain Authority 41/100 vs category average 35 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ipsen has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Instagram; no detected presence on Facebook, X (Twitter), YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Ipsen scores 57/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Ipsen has a limited AI-visibility profile at 57/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (65/100) and its weakest is recommendation likelihood (49/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a Moz Domain Authority of 41/100. The main gaps holding it back: no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Ipsen's main competitors include Sanofi (82/100), Novartis (73/100), Pfizer (89/100), AstraZeneca (82/100), Roche (93/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Ipsen and Roche are competitors in Healthcare. Brand Analyzer scores Ipsen at 82/100 and Roche at 93/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Ipsen include Sanofi (82/100), Novartis (73/100), Pfizer (89/100), AstraZeneca (82/100), Roche (93/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Ipsen has moderate AI-search visibility, scoring 57/100 on Brand Analyzer's AI visibility composite (visibility 65, trust 52, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Ipsen official site
Ipsen was founded in 1929. Ipsen operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Ipsen scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Ipsen official site
Ipsen is a global biopharmaceutical company headquartered in France, founded in 1929. It specializes in specialty care, particularly in oncology and rare diseases, and is dedicated to developing innovative treatments for areas of high unmet medical need.
Sources: Ipsen official site
Ipsen develops and advances a pipeline of specialty medicines targeting critical diseases such as cancer and rare disorders. The company focuses on innovation in biopharmaceutical research to bring new treatment options to patients where few or no approved therapies currently exist.
Sources: Ipsen official site
Ipsen can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Ipsen official site
Ipsen is known for its focus on specialty care biopharmaceuticals, particularly in oncology and rare diseases, and for its commitment to innovation in developing treatments for conditions with high unmet medical need.
Sources: Ipsen official site
Ipsen's offerings are used by patients suffering from cancer and rare diseases, as well as healthcare providers who prescribe and administer its treatments. The broader medical and scientific community also engages with Ipsen's research and innovations in specialty care.
Sources: Ipsen official site
Ranked closest to Ipsen: ALASTIN Skincare (82/100), Aetna (82/100), Aledade (82/100), Amgen (82/100).
A step up - brands to learn from: Oura (91/100), Olay (91/100).
Category leader: Elsevier (96/100).